Colleagues:

As a courtesy to Eli Lilly and Company, as directed by the FDA, ISMP is emailing you to notify you of a bamlanivimab Dear HCP letter containing the following message:

"Refer only to the FDA Authorized Fact Sheet for bamlanivimab for preparation and administration instructions and disregard a document entitled “Bamlanivimab Alternative Preparation and Administration Information.”

Please see the attached letter to review the Dear HCP letter.

Mike